TolC facilitates the intracellular survival and immunomodulation of Typhi in human host cells.

serovar Typhi (. Typhi) causes typhoid fever, a systemic infection that affects millions of people worldwide. . Typhi can invade and survive within host cells, such as intestinal epithelial cells and macrophages, by modulating their immune responses. However, the immunomodulatory capability of . Typhi in relation to TolC-facilitated efflux pump function remains unclear. The role of TolC, an outer membrane protein that facilitates efflux pump function, in the invasion and immunomodulation of . Typhi, was studied in human intestinal epithelial cells and macrophages. The deletion mutant of . Typhi was compared with the wild-type and its complemented strain in terms of their ability to invade epithelial cells, survive and induce cytotoxicity in macrophages, and elicit proinflammatory cytokine production in macrophages. The mutant, which has a defective outer membrane, was impaired in invading epithelial cells compared to the wild-type strain, but the intracellular presence of the mutant exhibited greater cytotoxicity and induced higher levels of proinflammatory cytokines ( and ) in macrophages compared to the wild-type strain. These effects were reversed by complementing the mutant with a functional gene. Our results suggest that TolC plays a role in . Typhi to efficiently invade epithelial cells and suppress host immune responses during infection. TolC may be a potential target for the development of novel therapeutics against typhoid fever.